Aziyo Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 22, 2023

Rhea-AI Summary

Aziyo Biologics, Inc. (Nasdaq: AZYO) announced the release of its fourth quarter and full year 2022 financial results scheduled for March 22, 2023, after market close. A management conference call and webcast will follow at 4:30 p.m. ET, featuring discussions on the financial performance and outlook. Investors can access the call via a dedicated phone line or through an online webcast. Aziyo focuses on developing biologic products aimed at enhancing compatibility between medical devices and patients, addressing a growing demand for implantable technologies. More information can be found on their official website.

Positive

• Scheduled release of Q4 and FY 2022 financial results, signaling transparency and engagement with investors.
• Focus on developing biologic products which may drive growth in the implantable technology sector.

Negative

• None.

SILVER SPRING, Md., March 15, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today announced that it will release its fourth quarter and full year 2022 financial results after market close on Wednesday, March 22, 2023. Members of the Company’s management team will host a conference call and webcast with accompanying slides starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here
U.S. Investors: 877-407-8029
International Investors: 201-689-8029
Conference ID: 13736040

Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Aziyo website at https://investors.aziyo.com/.

About Aziyo Biologics

Aziyo develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Aziyo’s mission is to humanize medical devices to improve patient outcomes. For more information, visit www.Aziyo.com.

Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com

Media:
Courtney Guyer
Aziyo Biologics, Inc.
PR@aziyo.com

FAQ

When will Aziyo Biologics release its Q4 and full year 2022 financial results?

Aziyo Biologics plans to release its financial results after market close on March 22, 2023.

What time is the conference call for Aziyo Biologics' financial results?

The conference call will start at 4:30 p.m. Eastern Time on March 22, 2023.

How can investors access the Aziyo Biologics conference call?

Investors can access the call by dialing 877-407-8029 for U.S. investors or 201-689-8029 for international investors.

What is the mission of Aziyo Biologics?

Aziyo's mission is to humanize medical devices to improve patient outcomes and compatibility.